LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis

Junzheng Chen; Xitian Huang; Weijun Wang; Hongcheng Xie; Jianfeng Li; Zhenfen Hu; Zhijian Zheng; Huiyong Li; Lingfang Teng

doi:doi:10.18632/aging.101645

← Back

Research Paper Volume 10, Issue 11 pp 3371—3381

LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis

Figure 1. CDKN2BAS is associated with HCC metastasis. (A) Expression profiles of LncRNA and mRNA from two groups of HCC tissue samples; (B) The expression of CDKN2BAS in metastatic and non-metastatic HCC tissues; (C) The expression of CDKN2BAS in cancer and paired adjacent non-cancer tissues of the metastatic group; (D) The expression of CDKN2BAS in human HCC cell lines. **P < 0.01.